Healthcare Specialty Enzymes Forecast Report 2025: A $7.94 Billion Market by 2030, Driven by Rising Chronic and Infectious Diseases and Expanding Diagnostic and The…

The Global Healthcare Specialty Enzymes Market is driven by the rising prevalence of chronic diseases and demand for advanced ...
Le Lézard

Citius Oncology Announces U.S. Commercial Launch of LYMPHIRtm, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)

Citius Oncology, Inc. ("Citius Oncology") , the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") , today announced the commercial launch of LYMPHIRtm (denileukin ...
The Malaysian Reserve

Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)

LYMPHIR now available nationwideCRANFORD, N.J., Dec. 1, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") ...
Nature

David Baltimore obituary: virologist whose enzyme discovery transformed understanding of cancer and HIV/AIDS

The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.
Verywell Health on MSN

Procapil vs. Minoxidil: Which Is Better for Hair Loss?

Minoxidil is an established, first-line treatment for hair loss. There is less evidence to support the efficacy of hair loss ...
Scientific Research Publishing

Loxoprofen-Induced Edema in an Elderly Male: A Case Report ()

Tanie, T. (2025) Loxoprofen-Induced Edema in an Elderly Male: A Case Report. Open Journal of Clinical Diagnostics, 15, ...